Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NTRBthis companyNutriband Inc.	$5.70	-1.86×	8.35×	27.38×	-6.42×	-123.8%	27.8%	-408.4%	-404.1%	-123.2%	-120.1%	-9.2%	0.04×	0.54×	-369.11×	6.36×	0.0%	3	34.78	1	C-
ACETAdicet Bio, Inc.	$3.11	-0.5×	0.36×	0×	-0.31×	-8.6%	0.0%	0.0%	0.0%	-73.4%	-70.2%	-167.1%	0.09×	0.22×	-3,392.06×	7.47×	0.0%	1	-6.93	3	B-
ACRVAcrivon Therapeutics, Inc. Common Stock	$1.64	-1.19×	0.82×	0×	-0.71×	-40.7%	0.0%	0.0%	0.0%	-69.2%	-73.0%	-70.4%	0.02×	0.51×	0×	7.69×	0.0%	1	-2.78	3	B-
CRVOCervoMed Inc.	$1.41	-2.65×	3.92×	0×	-2.34×	-51.0%	0.0%	0.0%	0.0%	-148.0%	-151.0%	-32.8%	0×	0.31×	0×	4.84×	0.0%	2	-3.92	2	C
FBIOFortress Biotech, Inc.	$1.96	-54.3×	2.05×	1.61×	-4.81×	-588.7%	66.9%	-111.0%	10.8%	13.7%	-50.0%	-64.4%	1.49×	0.25×	-8.06×	2.49×	0.7%	6	0.11	4	A
GANXGain Therapeutics, Inc.	$1.07	-5.28×	5.72×	0×	-4.48×	-46.1%	0.0%	0.0%	0.0%	-108.6%	-95.0%	-17.4%	0.04×	1.05×	0×	6.63×	0.0%	3	-6.34	2	C
Peer median	—	-2.65×	2.05×	0×	-2.34×	-46.1%	0.0%	0.0%	0.0%	-73.4%	-73.0%	-64.4%	0.04×	0.31×	0×	6.63×	0.0%	2	-3.92	3	—